HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) CME Activity An erratum has been published Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Iagaru, A. Articles by McDougall, I. R. Search for Related Content PubMed PubMed Citation Articles by Iagaru, A. Articles by McDougall, I. R.

Treatment of Thyrotoxicosis^*

Division of Nuclear Medicine and Molecular Imaging Program at Stanford, Department of Radiology, Stanford University Medical Center, Stanford, California

Correspondence: For correspondence or reprints contact: I. Ross McDougall, Department of Radiology, Stanford University Medical Center, 300 Pasteur Dr., Room H-0101, Stanford, CA 94305-5281. E-mail: ross.mcdougall{at}stanford.edu

In this review, the causes of thyrotoxicosis and the treatment of syndromes with increased trapping of iodine are discussed. The benefits and the potential side effects of 3 frequently used therapies—antithyroid medications, thyroidectomy, and ¹³¹I treatment—are presented. The different approaches to application of ¹³¹I treatment are described. Treatment with ¹³¹I has been found to be cost-effective, safe, and reliable.

Key Words: thyrotoxicosis • antithyroid medications • ¹³¹I treatment • thyroidectomy • Graves' disease • toxic nodular goiter

^* NOTE: FOR CE CREDIT, YOU CAN ACCESS THIS ACTIVITY THROUGH THE SNM WEB SITE (http://www.snm.org/ce_online) THROUGH MARCH 2008.

COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.

Related articles in JNM:

This Month in JNM

JNM 2007 48: 9a-10a. [Full Text]  

This article has been cited by other articles:

				E. S. Mittra, R. D. Niederkohr, C. Rodriguez, T. El-Maghraby, and I. R. McDougall Uncommon Causes of Thyrotoxicosis J. Nucl. Med., February 1, 2008; 49(2): 265 - 278. [Abstract] [Full Text] [PDF]

				A. Dardano, M. Ballardin, M. Ferdeghini, E. Lazzeri, C. Traino, N. Caraccio, G. Mariani, R. Barale, and F. Monzani Anticlastogenic Effect of Ginkgo Biloba Extract in Graves' Disease Patients Receiving Radioiodine Therapy J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4286 - 4289. [Abstract] [Full Text] [PDF]

				M. A. Walter, J. Muller-Brand, and B. Muller Antithyroid Drugs and Radioiodine and the Absence of Evidence J. Nucl. Med., August 1, 2007; 48(8): 1403a - 1403a. [Full Text] [PDF]

				I. R. McDougall and A. Iagaru Reply: Antithyroid Drugs and Radioiodine and the Absence of Evidence J. Nucl. Med., August 1, 2007; 48(8): 1403b - 1404. [Full Text] [PDF]